Prosetta Biosciences
PrivateLast Round
Series D
Dec 3, 2015
Est. Valuation
$20M
Total Funding Raised
$41.58M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Prosetta Biosciences is a biotechnology company that develops small-molecule antiviral therapeutics and advances drug discovery for oncology, neurodegenerative diseases, and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Prosetta Biosciences Comparables
Compare Prosetta Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PRISM BioLab Co., Ltd. | 77% | |
| HotSpot Therapeutics | 76% | |
| Talus Bio | 73% |
Prosetta Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Dec 3, 2015 | ||||
| Corporate Funding | Jul 31, 2012 | ||||
| Grant | Jun 8, 2012 | ||||
| Series A | May 18, 2007 |
Key People
Founding team and executive leadership
Prosetta Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| Alger | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 183% MoM, from 1.2K to 3.5K.
- Dec 3, 2015
$31.1M round with participation from Alger and Takeda.
Prosetta Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Prosetta Biosciences's valuation, stock price, and market status.
Is Prosetta Biosciences a public or private company?
Prosetta Biosciences is a private company.
What is the current stock price of Prosetta Biosciences?
Prosetta Biosciences is a private company, so its shares have no public market price. Caplight tracks Prosetta Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Prosetta Biosciences worth (valuation)?
Prosetta Biosciences's valuation is estimated at $20.0M based on funding round data.
Can I buy Prosetta Biosciences stock?
Prosetta Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Prosetta Biosciences's last funding round?
Prosetta Biosciences's most recent funding round was Series D on December 3, 2015.
Who are the main investors in Prosetta Biosciences?
Key investors in Prosetta Biosciences include U.S. Department of Health and Human Services, Alger.
Will Prosetta Biosciences IPO soon?
No public IPO plans have been announced for Prosetta Biosciences.
How can I track Prosetta Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Prosetta Biosciences's shares on secondary markets.